INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
CJ

Chung Jane

Director, Chief Executive OfficerCIK 0001872398

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 0
Max Insider Score21
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CJ
Chung JaneDirector, Chief Executive Officer
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
788 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    SUTRO BIOPHARMA, INC.Director, Chief Executive Officer · Dec 16, 2025
9
CJ
Chung JaneDirector, Chief Executive Officer
STROSUTRO BIOPHARMA, INC.
Tax withholding
F
$6,009
282 sh
Mar 4, 2026
Mar 6, 2026
traded Mar 4, 2026
+2d
SEC FORM 4

Evidence

9
CJ
Chung JaneDirector, Chief Executive Officer
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
788 sh
Mar 4, 2026Mar 6, 2026
traded Mar 4, 2026
+2dSEC FORM 4

Evidence

21
CJ
Chung JaneDirector, Chief Executive Officer
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
2,500 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence

17
CJ
Chung JaneDirector, Chief Executive Officer
STROSUTRO BIOPHARMA, INC.
Option exercise
M—
2,500 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence

13
CJ
Chung JaneDirector, Chief Executive Officer
STROSUTRO BIOPHARMA, INC.
Tax withholding
F$7,165
894 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence